Epidemiology, mathematical modelling and economics of Streptococcus pneumoniae : assessing the potential impact of vaccination

0044 English OPEN
Melegaro, Alessia;
  • Subject: QR | RA0421

This thesis explores aspects of Streptococcus pneumoniae (pneumococcus) epidemiology and control, in view of the possible widespread introduction of conjugate vaccines in England and Wales.\ud \ud A review and analysis of a range of different epidemiological data source... View more
  • References (26)
    26 references, page 1 of 3

    [1] Bedford H, de Louvois J, Halket S, Peckham C, Hurley R, Harvey D. Meningitis in infancy in England and Wales: follow up at age 5 years. BMJ 2001;323:1-5.

    [2] Laurichesse H, Grimaud 0, Waight P, Johnson AP, George R, Miller E. Pneumococcal bacteremia and meningitis in England and Wales, 1993 to 1995. Commun Dis Public Health 1998;1:22-7.

    [3] Lim WS, Macfarlane IT, Boswell TC, Harrison TO, Rose D, Leinonen M, et al, Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelines. Thorax 2001;56:296-301.

    [4] McIntosh EDG, Booy R. Invasive pneumococcal disease in England and Wales: what is the true burden and what is the potential for prevention using 7 valent pneumococcal conjugate vaccine? Arch Dis Child 2002;86:403-6.

    [5] Salisbury DM, Begg NT, Immunisation against infectious disease. In: The Green Book (Chap. 25), 1996. http://www.dh.gov.uk.

    [6] Black SB, Shinefield HR, Fireman B, Lewis E, Ray P, Hansen JR, et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Pediatr Infect Dis J 2000;19:187-95.

    [7] Black SB, Shinefield HR, Ling S, Hansen J, Fireman B, Spring D, et al. Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia. Pediatr Infect Dis J 2002;21:810-5.

    [8] Fireman B, Black SB, Shinefield HR, Lee J, Lewis E, Ray P. Impact of the pneumococcal conjugate vaccine on otitis media. Pediatr Infect Dis J 2003;22: 10-6. introduction of protein-polysaccharide conjugate vaccine. N Engl J Med 2003;348:1737-46.

    [29] Jacobs MR, Dagan R, Appelbaum PC, Burch DJ. Prevalence of antimicrobial-resistant pathogens in middle ear fluid: multinational study of 917 children with acute otitis media. Antimicrob Agents Chemother 1998;42:589-95.

    [30] Palmu AA, Herva E, Savolainen H, Karma P, Makela PH, Kilpi TM. Association of clinical signs and symptoms with bacterial findings in acute otitis media. Clin Infect Dis 2004;38:234-42.

  • Metrics
Share - Bookmark